Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...

Corbin Advisors, a strategic consultancy accelerating value realization globally, today released its quarterly Earnings Primer ®, which captures trends in institutional investor sentiment. The survey, ...

Omari Hutchinson relegation release clause expired yesterday evening with Brentford having offered the required £35 million ...